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Cardiovascular and metabolic diseases (CVMD) are major 
causes of death and disability worldwide. Although cardiovas-
cular disease mortality has decreased globally, the absolute 
number of deaths has increased in most regions of the world. 
Fortunately, risk factors causally associated with CVMD are 
widely known, and CVMD can be prevented through lifestyle 
modifications and existing risk management.1,2 Notwithstand-
ing, distributions of risk factors, their impact on disease devel-
opment, the prevalence of disease, and societal health deter-
minants can vary according to regional, racial, cultural, and 
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Mortalities from cardiovascular disease in Korea have decreased markedly over the past three decades. The major cardiovascular 
and metabolic risk factors, however, remain prevalent, and their burden on health is large. The Cardiovascular and Metabolic Dis-
eases Etiology Research Center (CMERC) planned a cohort study in order to identify novel risk factors and to develop evidence-
based prevention strategies of cardiovascular and metabolic diseases. The CMERC deliberately designed two prospective cohorts, 
a community-based general population cohort (the CMERC cohort) and its sister cohort (a hospital-based high-risk patient co-
hort), covering a broad spectrum of cardiovascular and metabolic diseases. This paper describes the CMERC cohort study of com-
munity-dwelling adults aged 30 to 64 years. A total of 8097 adults completed baseline measurement between 2013 and 2018. Base-
line measurements assessed socio-demographic factors, medical history, health-related behaviors, psychological health, social 
network and support, anthropometry, body composition, and resting blood pressure and comprised electrocardiography, carotid 
artery ultrasonography, fasting blood analysis, and urinalysis. Both active follow-up through an annual telephone survey and a 
5-year on-site health examination survey and passive follow-up through secondary data linkage with national databases, such as 
national death records, have been applied. Researchers interested in collaborative research may contact the corresponding author.
Key Words:  Cohort studies, cardiovascular diseases, metabolic diseases, adult, Republic of Korea
Brief Communication
pISSN: 0513-5796 · eISSN: 1976-2437
Received: March 21, 2019   Revised: May 14, 2019
Accepted: June 16, 2019
Corresponding author: Hyeon Chang Kim, MD, PhD, Department of Preventive 
Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, 
Seoul 03722, Korea.
Tel: 82-2-2228-1873, Fax: 82-2-392-8133, E-mail: hckim@yuhs.ac
•The authors have no potential conflicts of interest to disclose.
© Copyright: Yonsei University College of Medicine 2019
This is an Open Access article distributed under the terms of the Creative Com-
mons Attribution Non-Commercial License (https://creativecommons.org/licenses/
by-nc/4.0) which permits unrestricted non-commercial use, distribution, and repro-
duction in any medium, provided the original work is properly cited.
Yonsei Med J 2019 Aug;60(8):804-810
https://doi.org/10.3349/ymj.2019.60.8.804
805
Jee-Seon Shim, et al.
https://doi.org/10.3349/ymj.2019.60.8.804
economic status,3-5 which still need studies in various settings. 
The Cardiovascular and Metabolic Diseases Etiology Research 
Center (CMERC) planned a new cohort study in order to iden-
tify novel risk factors and to develop evidence-based preven-
tion strategies of CVMD in Korea. We have designed two pro-
spective cohorts, a community-based general population cohort 
(the CMERC cohort) and a hospital-based high-risk patient 
cohort (the CMERC-HI cohort).6 This paper focuses on the 
CMERC cohort. 
The CMERC cohort comprises community-dwelling adults 
who were free of cardiovascular diseases. Recruitment of the 
study participants and data collection were carried out at two 
research clinics managed by researchers at Yonsei University 
College of Medicine (YUCM clinic) in Seoul, Korea and at 
Ajou University School of Medicine (AUSM clinic) in Suwon, 
Korea. The YUCM clinic enrolled eligible adults from Seoul 
and the northwest parts of the capital area (Incheon, Goyang, 
and Gimpo), and the AUSM clinic targeted individuals living 
in the southern part of the capital area (Suwon, Yongin, and 
Hwaseong). The participants were recruited through adver-
tisements in local newspapers, ad posters in public areas, and 
by word-of-mouth from other participants. Cohort enrollment 
began in December 2013 and ended in March 2018. Adults aged 
30 to 64 years who had lived in their current residence for at 
least 8 months and had no plan to move out of the study area 
within 2 years and who were able to articulate their intention 
regarding study participation were eligible. Among them, 
those who had been diagnosed with myocardial infarction, 
heart failure, or stroke in their lifetime; had been diagnosed 
with cancer within the last 2 years; were currently undergoing 
cancer treatment; were participating in any randomized clini-
cal trials; or were currently pregnant were excluded. This 
study was scheduled to enroll 800 adults each year at each re-
search clinic over 5 years, resulting in a total of 8000 partici-
pants. The study protocols were approved by the institutional 
review boards of Severance Hospital, Yonsei University Health 
System, Seoul, Korea (4-2013-0661) and Ajou University Hos-
pital, Suwon, Korea (AJIRB-BMR-SUR-13-272). Written in-
formed consent was obtained from all participants prior to the 
baseline measurements. 
Baseline measurements assessed socio-demographic fac-
tors, medical history, health-related behaviors, psychological 
health, social network and support, anthropometry, and body 
composition and included cardiovascular examinations, blood 
analysis, and urinalysis (Table 1). Details on the study proto-
col have been reported previously.6 The majority of measure-
ments were conducted for all participants at the two research 
clinics, although there were some center-specific measure-
ments and additional measurements available for subsamples 
of the cohort. Among health-related behaviors, physical activity 
and sleep quality were assessed using the International Physi-
cal Activity Questionnaire-Short Form7 and the Berlin Ques-
tionnaire,8 respectively. Additionally, we included physical 
activity intensity and sleep/wake measurements using a three-
axis accelerometer (GENEActiv, Activinsights, Kimbolton, 
Cambridge, UK) for subsamples at the YUCM clinic and collect-
ed objective information on daily sleep and physical activity 
for 7 consecutive days. Dietary intake was assessed using the 
semi-quantitative food frequency questionnaire, which was de-
veloped and validated for dietary assessment of Korean adults 
in the Korea National Health and Nutrition Examination Sur-
vey (KNHANES).9,10 Among mental health measurements, de-
pressive symptoms and psychological responses to stressful life 
events were assessed using the Beck Depression Inventory-
II11,12 and the Life Experiences Survey Questionnaire,13,14 respec-
tively. Cognitive function was measured only for participants 
aged ≥50 years using the Mini-Mental State Estimation for de-
mentia screening.15 For social health assessment, “ego-centric 
social network” properties and social support were measured 
using the questionnaire developed for the Korean Social Life, 
Health, and Aging Project16: An ego-centric social network con-
sists of the participant (ego) and his/her social network mem-
bers (alters). Participants were asked to list social network 
members and to provide information about their relationship 
with each network member, each network member’s demo-
graphic characteristics, the frequency of talking or meeting 
with each network member, the degree of emotional closeness 
they feel to each network member, and social interactions be-
tween their social network members. Based on this collective 
information, each participant’s network properties were eval-
uated, including network size, density, content, composition, 
emotional closeness of alters, volume of contact with alters, and 
bridging potential. Physical health examinations were per-
formed on the same day as the participant answered the ques-
tionnaires. All participants fasted at least 8 hours. Anthropo-
metric measures, body composition, single-arm blood pressure 
(BP), resting electrocardiography, and carotid artery ultraso-
nography were measured in common at the two research clin-
ics. Fasting blood and urine samples were obtained, and bio-
assays were performed at a designated research laboratory. 
The YUCM clinic additionally performed simultaneous dou-
ble-arm BP measurements and radial artery applanation to-
nometry, as well as bioassays for hemostatic, inflammatory, and 
cardiac markers. Also, the YUMC clinic obtained information 
on liver fatness and cross-sectional areas of abdominal fat and 
thigh muscle from quantitative computerized tomography 
images according to the study protocol. Meanwhile, the AUSM 
clinic added oral glucose tolerance tests and measurements 
of adiponectin, C-peptide, heavy metals, and persistent or-
ganic pollutants in the blood. We also measured cellular im-
munity and immunosenescence biomarkers (CD4, CD8, 
CD28, and IL-6) known to be associated with cardiovascular 
disease17 for subsamples of the participants enrolled at both 
research clinics. Furthermore, we deposited biospecimens (se-
rum, plasma, buffy coat, and urine) to the National Biobank of 
Korea18 for future research. All procedures and measurement 
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were performed by trained research staff according to a pre-
determined protocol. The equipment used at each clinic was 
the same wherever possible, although some equipment did 
vary. To overcome possible measurement errors, we strictly 
followed a predefined protocol including all aspects of the ex-
amination, other than those related to the equipment, such as 
the participant’s position during the test, the measurement site, 
and the criteria for reading results. We also performed annual 
self-audits and regularly evaluated the inter-rater reliability of 
carotid intima-media thickness.19
A total of 8097 subjects (4060 in the YUCM clinic and 4037 
in the AUSM clinic) were enrolled and completed the baseline 
examination survey (Table 2). In total, 65.3% of the partici-
pants were women. Mean ages were 50.7 years for men and 
51.8 years for women. Men reported fewer healthy behaviors, 
a smaller social network size, and higher prevalences of cardio-
metabolic risk, such as obesity, hypertension, diabetes, and 
dyslipidemia, compared to women. 
The cohort has been followed up using both active (tele-
phone survey and on-site follow-up examination) and passive 
(data linkage with secondary data sources) strategies. The an-
nual telephone surveys are designed to collect information on 
changes in health status (new disease diagnosis or death), 
medical utilization (emergency room visits or hospitaliza-
tion), and current contact information, and are still ongoing. 
The response rates remain quite high (Table 3). On-site fol-
low-up health examination surveys are to be conducted at 
5-year intervals after the baseline measurement. We are cur-
rently conducting the first on-site follow-up examination for 
the participants enrolled during the first study year: as of mid-
Table 1. Summary of Variables Collected at Baseline for the CMERC Cohort Study 
Classification Contents Method
Socio-demographic factors Sex, age, education, marriage, cohabitation, economic status, occupation Questionnaire/interview
Medical history Past history, family history, current medication Questionnaire/interview
Reproductive factors 
Menarche, menopausal status, reproductive history, gestational diabetes and hypertension, oral 
contraceptive use, hormone replacement therapy
Questionnaire/interview
Health-related behaviors Smoking, drinking, diet, physical activity, sleep, obstructive sleep apnea risk Questionnaire/interview
Physical activity and sleep* 3-D accelerometer
Psychological health Depression, stressful life events  Questionnaire/self-report
Cognitive function† Questionnaire/interview†
Social network analysis
Eco-centric network properties (network size, density, content, composition, emotional closeness 
of alters, volume of contact with alters, bridging potential)
Questionnaire/interview
Social support Social support from a spouse or social network member Questionnaire/interview
Anthropometric measures Height, weight, circumferences (arm, waist, hip, thigh) Examination 
Weight at 20 years Questionnaire/interview
Heaviest weight in lifetime Questionnaire/interview
Body composition Body fat, lean body mass, muscle mass Examination (bioimpedance)
Bone mineral density, body composition Examination
Blood pressure Single-arm blood pressure Examination 
Dual-arm blood pressure‡ Examination
Radial artery tonometry Augmentation index‡ Examination
Electrocardiogram 12-channel electrocardiogram Examination
Carotid ultrasonography Carotid intima thickness, plaque, bulb Examination
Biochemical indicators
Urine, common items Proteins, ketones, blood, bilirubin, and nitrates Laboratory analysis
Blood, common items 
CBC, total protein, albumin, glucose, insulin, triglyceride, total cholesterol, HDL-cholesterol, BUN, 
creatinine, uric acid, AST, ALT, γ-GTP, 25-OH vitamin D, hs-CRP, HbA1c
Laboratory analysis
Blood, additional items*
Lipid markers (LDL-cholesterol), hemostatic markers (prothrombin time, activated partial 
thromboplastin time, factor VII, factor VIII, fibrinogen, D-dimer), inflammatory markers 
(IL-1α, IL-β1, IL-6, TNF-α, TNF-β, CD40 ligand), cardiac marker (hs-troponin T)
Laboratory analysis*
Glucose metabolic markers (OGTT, adiponectin, c-peptide), heavy metals (Pb, Cd, Hg), 
persistent organic pollutants (As, bisphenol A) 
Laboratory analysis*
Immunosenescence biomarkers (CD4, CD8, CD28, CD57, and IL-6) Laboratory analysis*
CMERC, Cardiovascular and Metabolic Diseases Etiology Research Center; CBC, complete blood count; HDL, high density lipoprotein; BUN, blood urea nitrogen; 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GTP, gamma-glutamyl transferase; hs-CRP, high sensitivity C-reactive protein; HbA1c, hemo-
globin A1c; LDL, low density lipoprotein; IL, interleukin; TNF, tumor necrosis factor; OGTT, oral glucose tolerance test; Pb, lead; Cd, cadmium; Hg, mercury; As, 
asernic.
*Measured only for a subgroup of participants; † Measured only for participants aged ≥50 years; ‡Measured only at Yonsei University College of Medicine clinic.
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Table 2. Distribution of Selected Baseline Characteristics in the CMERC Cohort  
Variables Total (n=8097) Men (n=2808) Women (n=5289)
Socio-demographic factors 
Age (yr) 51.4±8.7 50.7±9.3 � 51.8±8.3
Marriage, married and living with a spouse 7057 (87.2) 2598 (92.5) 4459 (84.3)
Monthly income (10000 won) 500 (333–700) 500 (400–800) 500 (300–700)
Health-related behaviors 
Current smoking 1060 (13.1)   923 (32.9) 137 (2.6)
Current drinking (≥1 unit/month) 4433 (54.8) 2180 (77.6) 2253 (42.6)
Regular walking (≥30 minutes/day)  3747 (46.3) 1321 (47.1) 2426 (45.9)
Energy intake (kcal) 2283.2±808.9 2637.4±897.2 � 2089.9±683.0
Sleep duration (hr)    6.8±1.2 6.9±1.1   6.8±1.2
Social network proprieties 
Network size (n, 0–6)    3.43±1.67 3.22±1.76   3.54±1.61
Proportion of kin within a network    0.50±0.35 0.47±0.36   0.52±0.34
Proportion of cohabitants within a network    0.39±0.30 0.46±0.33   0.36±0.28
Average closeness to alters (score, 1–4)    3.16±0.61 3.20±0.61   3.13±0.61
Overall volume of contact (days/year)    605.5±331.6 583.5±317.6   617.2±338.2
Network density    0.66±0.28 0.67±0.28   0.65±0.28
Anthropometrics 
Height (cm) 162.1±8.2 � 170.5±6.0 � � � � 157.6±5.2 � �
Weight (kg)    63.6±11.1 73.0±10.1 58.6±7.9
Body mass index (kg/m2)  24.1±3.1 25.1±2.9 � � 23.6±3.0
Waist circumference (cm)  82.3±9.1 87.6±7.9 � � 79.4±8.4
Total body fat (%)  30.1±7.2 24.4±5.7 � � 33.2±6.0
Cardiometabolic disease status 
Obesity* 2860 (35.3) 1383 (49.3) 1477 (27.9)
Hypertension† 2047 (25.3)   961 (34.2) 1086 (20.5)
Diabetes mellitus‡ 612 (7.6)   320 (11.4) 292 (5.5)
Hypercholesterolemia§ 1719 (21.3)   507 (18.1) 1212 (22.9)
Hypertriglyceridemia‖ 1854 (22.9)   829 (29.5) 1025 (19.4)
Low HDL cholesterol¶   823 (10.2)   520 (18.5) 303 (5.7)
Carotid intima-media thickness (mm)  
Right    0.630±0.123 0.647±0.132   0.622±0.117
Left    0.636±0.137 0.654±0.134   0.627±0.138
Fasting blood analysis 
Glucose (mg/dL)    95.5±20.5 99.8±23.8   93.2±18.1
HbA1c (%)    5.7±0.7 5.8±0.8   5.7±0.6
Insulin (uIU/mL)    9.2±3.9 9.6±4.4   9.0±3.6
Triglyceride (mg/dL)  131.6±92.9 161.4±24.3 � � 115.8±65.6
Total cholesterol (mg/dL) 195.1±34.7 192.9±34.4 � � 196.3±34.8
HDL-cholesterol (mg/dL)    55.9±14.1 49.9±12.3   59.1±13.9
BUN (mg/dL)  14.6±3.8 15.2±3.8 � � 14.3±3.7
Creatinine (mg/dL)    0.9±0.2 1.0±0.2   0.8±0.1
Uric acid (mg/dL)    4.9±1.3 5.9±1.2   4.3±0.9
AST (IU/L)    25.7±13.3 27.4±10.3   24.8±14.6
ALT (IU/L)    25.1±18.4 30.6±19.6   22.1±17.0
γ-GTP (IU/L)    31.1±42.7 47.1±55.9   22.5±30.3
CRP (mg/L)    1.4±4.0 1.7±4.8   1.2±3.5
25-(OH) vitamin D (ng/mL)  16.3±8.6 15.8±6.9 � � 16.5±9.3
CMERC, Cardiovascular and Metabolic Diseases Etiology Research Center; HDL, high-density lipoprotein; HbA1c, hemoglobin A1c; BUN, blood urea nitrogen; 
ALT, alanine aminotransferase; AST, aspartate aminotransferase; γ-GTP, gamma-glutamyl transferase; CRP, C-reactive protein.
Values are presented as a mean±standard deviation, median (interquartile range), or n (%).
*Obesity was defined as a body mass index ≥25.0 kg/m2; †Hypertension was defined as either a systolic or a diastolic blood pressure ≥140 mm Hg or ≥90 mm Hg, 
or when participants self-reported antihypertensive drug treatment; ‡Diabetes was defined as either a fasting glucose level ≥126 mg/dL or when participants 
self-reported anti-diabetic treatment, such as taking a hypoglycemic agent or insulin; §Hypercholesterolemia was defined as either a serum cholesterol level ≥240 
mg/dL or when participants self-reported lipid-lowering drug treatment; ‖Hypertriglyceridemia was defined as either a serum triacylglycerol level ≥200 mg/dL or 
when participants self-reported lipid-lowering drug treatment; ¶Low HDL cholesterol was defined as an HDL cholesterol level <40 mg/dL.  
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May 2019, 500 participants completed the on-site follow-up 
survey. For passive follow-up, the CMERC obtained written 
consent to use personal information for secondary data link-
age from each participant. We recently linked CMERC cohort 
information with the national death registry maintained by 
Statistics Korea. Among participants enrolled in the first three 
years who agreed to data linkage (n=4889), four deaths were 
officially identified through December 31, 2016, which was 
consistent with the results from the annual telephone surveys. 
Regular data-linkage updates and passive follow-up using oth-
er data sources, such as the National Health Insurance Claims 
database and the National Health Screening database, will be 
performed. 
As the CMERC cohort has only recently completed the 
baseline examinations of study participants, the findings pub-
lished so far primarily cover the study methodologies or the 
results of cross-sectional analysis of the baseline data.6,19-32 
Several studies using this cohort are currently either ongoing 
or being processed for publication. Some of the key findings 
are as follows: We compared low density lipoprotein (LDL)-
cholesterol estimations using various formulas with direct 
measurement of LDL-cholesterol20 and found that the accura-
cies of the formulas were differed considerably according to 
triglycerides levels. We also found large inter-arm differences 
in BP in a small portion of study participants and that high 
systolic BP, chronic inflammation, and obesity were associat-
ed with larger differences in inter-arm BP.21 Meanwhile, al-
though a positive association between glycosylated hemoglo-
bin (HbA1c) and estimated average glucose levels is widely 
known, there has been no study thereof targeting the Korean 
population. Indeed, we found an apparent association be-
tween HbA1c level and mean blood glucose level.22 Visceral 
fat mass measured using dual-energy X-ray absorptiometry 
was found to be a stronger indicator of diabetes and prediabe-
tes than other anthropometric obesity indices.23 Other reports 
describe novel biomarkers for exposure to environmental pol-
lutants, inflammation, and immune-mediated aging process-
es.24-32 We have reported on the potential impact of cadmium 
exposure on an association between inflammation generated 
by lipopolysaccharides and metabolic syndrome,24 an inde-
pendent association between bisphenol A exposure and sys-
temic inflammation,25 and a positive association between 
blood mercury concentration and visceral adipose tissue 
content.26 While it is known that T cells play a role in the de-
velopment of coronary artery diseases (CADs), it remains un-
clear which type of T cells are responsible for the pathogene-
sis. We found that senescent CD8+ T cells might be associated 
with the pathogenesis of CAD through their pro-inflammato-
ry and highly cytotoxic capacities.31 In another study, we sug-
gested that immune dysfunction mediated by the key uremic 
toxin, indoxyl sulphate, may provoke endothelial damage in 
patients with end-stage renal disease, thereby elevating the 
risk of cardiovascular disease.32
The CMERC cohort study has several strengths and weak-
nesses. The important strength is its plethora of information, 
including emerging risk factors and biomarkers, as well as well-
established traditional risk factors, of CVMD, along with bio-
specimens for future research. Among the emerging risk factors 
measured, social network characteristics and immunosenes-
cent biomarkers are particularly unique. While social environ-
ments have been deemed to have a major influence on both 
the adoption of health behaviors and the health status of adults, 
the relationships between social support networks and health 
have not been well studied. Increasing evidence supports that 
immunosenescence may play some role in the development 
and progression of chronic degenerative disease; however, the 
underlying mechanisms are still unclear. Another strength is 
the study design. The CMERC cohort of community-dwelling 
participants and the CMERC-HI cohort of high-risk patients 
comprise measurements of many risk factors using the same 
methods. Thus, the two sister cohorts covering a broad spec-
trum of CVMD enables us to conduct primary and secondary 
prevention studies. The CMERC cohort has weaknesses, how-
ever, that should be considered. The main weakness is the lim-
ited generalizability that often occurs in cohort studies. The 
study population was not randomly drawn from the entire 
target population, which needs to be considered when apply-
ing the results to the target population. Another limitation is 
that some measurements were performed using different 
equipment available at each research clinic. Nevertheless, this 
drawback is confined to examinations that require particular-
ly expensive equipment, such as imaging studies, and we have 
made efforts to avoid measurement errors due to reasons oth-
er than the equipment, such as the operator or the patient’s 
position during the measurement. 
The baseline measurement data and bio-specimens of the 
CMERC cohort have been deposited at the National Biobank 
of Korea managed by the Korea National Institute of Health 
(KNIH). Currently, access to the data is limited to researchers, 
but will soon be open to others. Further information is available 
on the KNIH website (http://www.nih.go.kr/index.es?sid=a5). 
Individuals can gain access to the dataset after receiving ap-
Table 3. Numbers and Response Rates of Annual Telephone Follow-Up 
Surveys
Enrollment Annual telephone follow up 
Period n 1st 2nd 3rd 4th 
2013–2014 1608 1603 (99.7)* 1594 (99.1) 1576 (98.0) 1565 (97.3)
2014–2015 1623 1616 (99.6) 1611 (99.3) 1602 (98.7) -
2015–2016 1658 1651 (99.6) 1640 (98.9) - -
2016–2017 1665 1660 (99.7) - - -
2017–2018 1543 - - - -
Total 8097 6530 (99.6)† 4845 (99.1)† 3178 (98.4)† 1565 (97.3)†
Values are presented as n (%).
*Means the proportion of followed cases among enrolled cases of each peri-
od; †Means the proportion followed cases for each follow-up time. 
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proval from the research proposal committee of the KNIH. 
Also, researchers interested in collaborative research can con-
tact the CMERC principal investigator, Hyeon Chang Kim, at 
hckim@yuhs.ac.
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